Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference

被引：36

作者：

Ross, Anna Laura ^{[8
]}

Brave, Andreas ^{[6
,7
]}

Scarlatti, Gabriella ^{[5
]}

Manrique, Amapola ^{[4
]}

Buonaguro, Luigi ^{[1
,2
,3
]}

机构：

[1] Fdn G Pascale, Ist Nazl Tumori, Mol Biol Lab, I-80131 Naples, Italy

[2] Fdn G Pascale, Natl Canc Inst, Viral Oncogenesis & AIDS Reference Ctr, I-80131 Naples, Italy

[3] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA

[4] Global HIV Vaccine Enterprise, New York, NY USA

[5] Ist Sci San Raffaele, Div Immunol Transplant & Infect Dis, Viral Evolut & Transmiss Unit, I-20132 Milan, Italy

[6] Swedish Inst Infect Dis Control, Dept Virol, Stockholm, Sweden

[7] Swedish Inst Infect Dis Control, Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden

[8] French Natl Agcy Res AIDS & Viral Hepatitis, HIV Vaccine Res Unit, Paris, France

来源：

LANCET INFECTIOUS DISEASES | 2010年 / 10卷 / 05期

关键词：

HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; HUMAN MONOCLONAL-ANTIBODY; ELICITS NEUTRALIZING ANTIBODIES; RECOMBINANT MEASLES VIRUSES; VESICULAR STOMATITIS-VIRUS; HIV-1/SIV CHIMERIC VIRUS; MUCOSAL HOMING PHENOTYPE; YELLOW-FEVER VACCINE; IMMUNE-RESPONSES;

D O I：

10.1016/S1473-3099(10)70069-4

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The search for an HIV/AIDS vaccine is steadily moving ahead, generating and validating new concepts in terms of novel vectors for antigen delivery and presentation, new vaccine and adjuvant strategies, alternative approaches to design HIV-1 antigens for eliciting protective cross-neutralising antibodies, and identification of key mechanisms in HIV infection and modulation of the immune system. All these different perspectives are contributing to the unprecedented challenge of developing a protective HIV-1 vaccine. The high scientific value of this massive effort is its great impact on vaccinology as a whole, providing invaluable scientific information for the current and future development of new preventive vaccine as well as therapeutic knowledge-based infectious-disease and cancer vaccines.

引用

页码：305 / 316

页数：12

共 50 条

[31] w Current views on the potential for development of a HIV vaccine
Cohen, Kristen W.
Frahm, Nicole
EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (03) : 295 - 303
[32] New approaches to HIV vaccine development
Haynes, Barton F.
CURRENT OPINION IN IMMUNOLOGY, 2015, 35 : 39 - 47
[33] Progress in filovirus vaccine development: evaluating the potential for clinical use
Falzarano, Darryl
Geisbert, Thomas W.
Feldmann, Heinz
EXPERT REVIEW OF VACCINES, 2011, 10 (01) : 63 - 77
[34] Tuberculosis Vaccine Development: Progress in Clinical Evaluation
Sable, Suraj B.
Posey, James E.
Scriba, Thomas J.
CLINICAL MICROBIOLOGY REVIEWS, 2020, 33 (01)
[35] Recent progress in dengue vaccine research and development
Miller, Nicholas
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (01) : 31 - 38
[36] Progress and prospect of polysaccharides as adjuvants in vaccine development
Liang, Xinlong
Zhou, Jiaying
Wang, Mengmeng
Wang, Jing
Song, Houhui
Xu, Yigang
Li, Yuan
VIRULENCE, 2024, 15 (01)
[37] Current concepts and progress in RSV vaccine development
Guvenel, Aleks K.
Chiu, Christopher
Openshaw, Peter J. M.
EXPERT REVIEW OF VACCINES, 2014, 13 (03) : 333 - 344
[38] Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
Girard, Marc P.
Osmanov, Saladin
Assossou, Olga M.
Kieny, Marie-Paule
VACCINE, 2011, 29 (37) : 6191 - 6218
[39] Improved outlook on HIV-1 prevention and vaccine development
Vasan, Sandhya
Michael, Nelson L.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (08) : 983 - 994
[40] Systems vaccinology: its promise and challenge for HIV vaccine development
Nakaya, Helder I.
Pulendran, Bali
CURRENT OPINION IN HIV AND AIDS, 2012, 7 (01) : 24 - 31

← 1 2 3 4 5 →